United States · FDA National Drug Code directory
basiliximab
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17088-0370_337d4592-4df4-4412-ae08-e70fa9b97ccd
- Product NDC
- 17088-0370
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- basiliximab
- Labeler
- Novartis Pharma Stein AG
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 19980512
- Source listing expiry
- 20271231
Source-listed ingredients
- BASILIXIMAB — 10 mg/2.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2.5 mL in 1 VIAL, SINGLE-USE (17088-0370-1) · 17088-0370-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →